Exercise Therapy for PAD Using Mobile Health

🩺 Protocol Summary

Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans have limited access to supervised exercise therapy, a facility-based program proven to improve walking ability in PAD, which is poorly attended due to the inconvenience and cost of attending a 12-week program with multiple weekly sessions. This CDA-2 application will investigate the feasibility of home-based exercise therapy (HBET) delivered using mobile health (mHealth) technologies in Veterans with symptomatic PAD. We will partner with the MOVE! program to deliver HBET through group behavioral coaching and a novel wearable activity monitor in a newly proposed program called Smart MOVE!. There is a clear need to provide effective and convenient alternatives to supervised exercise for Veterans with PAD. This study will provide evidence to proceed with Smart MOVE!, a much-needed patient-centered rehabilitation program for Veterans with PAD.

Primary Research Facility: Atlanta VA Medical and Rehab Center, Decatur, GA (Decatur, Georgia)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Peripheral Artery Disease?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged 40 Years or older?

🔍 Protocol Specified Minimum Age: 40 Years

Able to attend required clinic visits at Atlanta VA Medical and Rehab Center, Decatur, GA (Decatur, Georgia)?

🔍 Logistical Requirement: Site at Atlanta VA Medical and Rehab Center, Decatur, GA

📍 Primary Site Map

Site: Atlanta VA Medical and Rehab Center, Decatur, GA — Decatur, Georgia

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.